What is Corcept Therapeutics Inc.'s Market Cap?

Corcept Therapeutics Inc.'s Market Cap is $12.3B, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s Enterprise Value?

Corcept Therapeutics Inc.'s Enterprise Value is $12.0B, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s Trailing P/E?

Corcept Therapeutics Inc.'s Trailing P/E is 223.5×, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s Price / Sales?

Corcept Therapeutics Inc.'s Price / Sales is 14.8×, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s EV / Revenue?

Corcept Therapeutics Inc.'s EV / Revenue is 14.5×, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s EV / EBITDA?

Corcept Therapeutics Inc.'s EV / EBITDA is 1486.0×, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s Revenue (TTM)?

Corcept Therapeutics Inc.'s Revenue (TTM) is $830.8M, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s Net Income (TTM)?

Corcept Therapeutics Inc.'s Net Income (TTM) is $55.2M, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s EBITDA?

Corcept Therapeutics Inc.'s EBITDA is $8.1M, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s Diluted EPS (TTM)?

Corcept Therapeutics Inc.'s Diluted EPS (TTM) is 0.51, based on as-reported figures from SEC (XBRL) filings.

Corcept Therapeutics Inc. (CORT) Financial Statements

Corcept Therapeutics Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S8QGV1

XNAS · usd

114.11▲ 0.13 (0.11%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close113.98

Day's Range108.25 – 115.28

52-Week Range28.66 – 126.38

Volume1.0M

Avg Volume1.0M

Share Statistics

Shares Outstanding

Employees730

ExchangeXNAS

Listed2004-04-14

Share count as of July 22, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Corcept Therapeutics Inc. (CORT)

What is Corcept Therapeutics Inc.'s Market Cap?: Corcept Therapeutics Inc.'s Market Cap is $12.3B, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s Enterprise Value?: Corcept Therapeutics Inc.'s Enterprise Value is $12.0B, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s Trailing P/E?: Corcept Therapeutics Inc.'s Trailing P/E is 223.5×, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s Price / Sales?: Corcept Therapeutics Inc.'s Price / Sales is 14.8×, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s EV / Revenue?: Corcept Therapeutics Inc.'s EV / Revenue is 14.5×, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s EV / EBITDA?: Corcept Therapeutics Inc.'s EV / EBITDA is 1486.0×, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s Revenue (TTM)?: Corcept Therapeutics Inc.'s Revenue (TTM) is $830.8M, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s Net Income (TTM)?: Corcept Therapeutics Inc.'s Net Income (TTM) is $55.2M, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s EBITDA?: Corcept Therapeutics Inc.'s EBITDA is $8.1M, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s Diluted EPS (TTM)?: Corcept Therapeutics Inc.'s Diluted EPS (TTM) is 0.51, based on as-reported figures from SEC (XBRL) filings.